Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Inactivated, entire Bordetella pertussis bacteria containing a full complement of bacterial antigens used to stimulate a broad immune response. Key components include pertussis toxin (PT), filamentous hemagglutinin (FHA), fimbriae (Fim), and pertactin (PRN).
Induction of humoral and cellular immunity against Bordetella pertussis through exposure to a wide array of bacterial antigens.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bordetella pertussis Antigens (Whole Cell).